Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study Academic Article 2019 uri icon

authors

  • Troya J
  • Samperiz G
  • Bachiller P
  • BOIX MARTINEZ, VICENTE
  • Barrufet P
  • Cervero M
  • Sanz J
  • Solís J
  • Yllescas M
  • Valencia E
  • Montejano R
  • GESIDA-8715 Study Group
  • Ryan P
  • Gómez C
  • Matarranz M
  • Matarranz M
  • Vera F
  • Sepúlveda M
  • Santos I

publication date

  • 2019